These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12101625)

  • 21. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
    Grassi MC; Enea D; Ferketich AK; Lu B; Nencini P
    Nicotine Tob Res; 2009 Sep; 11(9):1114-21. PubMed ID: 19654237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antismoking pills for cardiac patients, too? Every third one rebounds].
    MMW Fortschr Med; 2002 Feb; 144(8):51. PubMed ID: 11910827
    [No Abstract]   [Full Text] [Related]  

  • 24. Breaking the ties of nicotine dependence.
    Bennett SM; Andrews JO; Heath JH
    Nurse Pract; 2007 Nov; 32(11):36-45; quiz 45-6. PubMed ID: 18075457
    [No Abstract]   [Full Text] [Related]  

  • 25. Bupropion for smokers. Bupropion may not be as good as editorial implies.
    Harrison C
    BMJ; 2001 Feb; 322(7283):431; author reply 432-3. PubMed ID: 11179179
    [No Abstract]   [Full Text] [Related]  

  • 26. [Methods and cost effectiveness of nicotine abstinence].
    Górecka D
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():79-82. PubMed ID: 15524024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Zyban in smoking cessation--what about medical ethics?].
    Tonstad S
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):231. PubMed ID: 11475211
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB
    Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
    Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
    Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More on PHARMAC and tobacco control in New Zealand.
    Metcalfe S; Moodie P
    N Z Med J; 2006 Jan; 119(1228):U1837. PubMed ID: 16462938
    [No Abstract]   [Full Text] [Related]  

  • 31. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
    Dalsgareth OJ; Hansen NC; Søes-Petersen U; Evald T; Høegholm A; Barber J; Vestbo J
    Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Safety of Zyban administration in nicotine dependence treatment].
    Goniewicz ML; Czogała J
    Przegl Lek; 2004; 61(10):1200-2. PubMed ID: 15794289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The participation of health professionals in a smoking-cessation programme positively influences the smoking cessation advice given to patients.
    Puska PM; Barrueco M; Roussos C; Hider A; Hogue S
    Int J Clin Pract; 2005 Apr; 59(4):447-52. PubMed ID: 15853863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'.
    Holt S; Harwood M; Aldington S; Beasley R
    N Z Med J; 2005 Jun; 118(1216):U1502. PubMed ID: 15937536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
    Paul CL; Tzelepis F; Walsh RA; Turner R
    Drug Alcohol Rev; 2007 Jul; 26(4):429-33. PubMed ID: 17564880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.
    Covey LS; Glassman AH; Jiang H; Fried J; Masmela J; LoDuca C; Petkova E; Rodriguez K
    Addiction; 2007 Aug; 102(8):1292-302. PubMed ID: 17624979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National trends in the provision of smoking cessation aids within the Veterans Health Administration.
    Jonk YC; Sherman SE; Fu SS; Hamlett-Berry KW; Geraci MC; Joseph AM
    Am J Manag Care; 2005 Feb; 11(2):77-85. PubMed ID: 15726855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers.
    Killen JD; Robinson TN; Ammerman S; Hayward C; Rogers J; Stone C; Samuels D; Levin SK; Green S; Schatzberg AF
    J Consult Clin Psychol; 2004 Aug; 72(4):729-35. PubMed ID: 15301658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stat bite: Medicaid coverage of tobacco-dependence treatments.
    J Natl Cancer Inst; 2008 Apr; 100(7):460. PubMed ID: 18364498
    [No Abstract]   [Full Text] [Related]  

  • 40. How does bupropion work as a smoking cessation aid?
    Warner C; Shoaib M
    Addict Biol; 2005 Sep; 10(3):219-31. PubMed ID: 16109583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.